Polyamine intake, dietary pattern, and cardiovascular disease

Medical Hypotheses

Volumn 75, Issue 3, 2010, Pages 299-301

  Soda, Kuniyasu ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYTOKINE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; NITRIC OXIDE; OMEGA 3 FATTY ACID; POLYAMINE;

AGE; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; DIETARY INTAKE; ERYTHROCYTE; FRUIT; HUMAN; INCIDENCE; LEGUME; LEUKOCYTE; LIFESTYLE; LONGEVITY; MEDITERRANEAN DIET; MORTALITY;

MUS;

EID: 77955564196     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.03.008     Document Type: Article

References (46)

1. Ignarro L.J., Balestrieri M.L., Napoli C. Nutrition, physical activity, and cardiovascular disease: an update. Cardiovasc Res 2007, 73:326-340.
2. Daviglus M.L., Stamler J., Orencia A.J., Dyer A.R., Liu K., Greenland P., et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 1997, 336:1046-1053.
3. The Lipid Research Clinics Coronary Primary Prevention Trial Results. I. Reduction in incidence of coronary heart disease. JAMA 1984;251:351-64.
4. The Lipid Research Clinics Coronary Primary Prevention Trial Results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984;251:365-74.
5. Oomen C.M., Ocke M.C., Feskens E.J., van Erp-Baart M.A., Kok F.J., Kromhout D. Association between trans-fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet 2001, 357:746-751.
6. Wang C., Harris W.S., Chung M., Lichtenstein A.H., Balk E.M., Kupelnick B., et al. N-3 fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 2006, 84:5-17.
7. Lichtenstein A.H., Appel L.J., Brands M., Carnethon M., Daniels S., Franch H.A., et al. Summary of American Heart Association Diet and Lifestyle Recommendations revision 2006. Arterioscler Thromb Vasc Biol 2006, 26:2186-2191.
8. Martinez-Gonzalez M.A., Bes-Rastrollo M., Serra-Majem L., Lairon D., Estruch R., Trichopoulou A. Mediterranean food pattern and the primary prevention of chronic disease: recent developments. Nutr Rev 2009, 67(Suppl. 1):S111-116.
9. Roman B., Carta L., Martinez-Gonzalez M.A., Serra-Majem L. Effectiveness of the Mediterranean diet in the elderly. Clin Interv Aging 2008, 3:97-109.
10. Bardócz S., Grant G., Brown D.S., Ralph A., Pusztai A. Polyamines in food-implications for growth and health. J Nutr Biochem 1993, 4:66-71.
11. Cipolla B.G., Havouis R., Moulinoux J.P. Polyamine contents in current foods: a basis for polyamine reduced diet and a study of its long term observance and tolerance in prostate carcinoma patients. Amino Acids 2007, 33:203-212.
12. Nishibori N., Fujihara S., Akatuki T. Amounts of polyamines in foods in Japan and intake by Japanese. Food Chem 2007, 100:491-497.
13. Nishimura K., Shiina R., Kashiwagi K., Igarashi K. Decrease in polyamines with aging and their ingestion from food and drink. J Biochem 2006, 139:81-90.
14. Moss M., Freed D. The cow and the coronary: epidemiology, biochemistry and immunology. Int J Cardiol 2003, 87:203-216.
15. Artaud-Wild S.M., Connor S.L., Sexton G., Connor W.E. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox. Circulation 1993, 88:2771-2779.
16. Segall J.J. Is milk a coronary health hazard?. Br J Prev Soc Med 1977, 31:81-85.
17. Calder P.C. N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006, 83:1505S-1519S.
18. Kinsella J.E., Lokesh B., Stone R.A. Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms. Am J Clin Nutr 1990, 52:1-28.
19. Mozaffarian D. Trans fatty acids - effects on systemic inflammation and endothelial function. Atheroscler Suppl 2006, 7:29-32.
20. Nettleton J.A., Steffen L.M., Mayer-Davis E.J., Jenny N.S., Jiang R., Herrington D.M., et al. Dietary patterns are associated with biochemical markers of inflammation and endothelial activation in the multi-ethnic study of atherosclerosis (MESA). Am J Clin Nutr 2006, 83:1369-1379.
21. Estruch R., Martinez-Gonzalez M.A., Corella D., Salas-Salvado J., Ruiz-Gutierrez V., Covas M.I., et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Int Med 2006, 145:1-11.
22. Esposito K., Marfella R., Ciotola M., Di Palo C., Giugliano F., Giugliano G., et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004, 292:1440-1446.
23. Zhang M., Caragine T., Wang H., Cohen P.S., Botchkina G., Soda K., et al. Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: a counter regulatory mechanism that restrains the immune response. J Exp Med 1997, 185:1759-1768.
24. Soda K., Kano Y., Nakamura T., Kasono K., Kawakami M., Konishi F. Spermine, a natural polyamine, suppresses LFA-1 expression on human lymphocyte. J Immunol 2005, 175:237-245.
25. Zhu S., Ashok M., Li J., Li W., Yang H., Wang P., et al. Spermine protects mice against lethal sepsis partly by attenuating surrogate inflammatory markers. Mol Med 2009, 15:275-282.
26. Soda K., Dobashi Y., Kano Y., Tsujinaka S., Konishi F. Polyamine-rich food decreases age-associated pathology and prolongs murine longevity. Exp Gerontology 2009, 44:727-732.
27. Kasiske B.L. Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int 1987, 31:1153-1159.
28. Soda K., Kano Y., Takao K., Lefor A., Konishi F. Long-term polyamine intake increases blood polyamine concentration. J Nutr Sci Vitaminol 2009, 55:361-366.
29. Kano Y., Soda K., Nakamura T., Saitoh M., Kawakami M., Konishi F. Increased blood spermine levels decrease the cytotoxic activity of lymphokine-activated killer cells: a novel mechanism of cancer evasion. Cancer Immunol Immunother 2007, 56:771-781.
30. Cohen L.F., Lundgren D.W., Farrell P.M. Distribution of spermidine and spermine in blood from cystic fibrosis patients and control subjects. Blood 1976, 48:469-475.
31. Cooper K.D., Shukla J.B., Rennert O.M. Polyamine compartmentalization in various human disease states. Clin Chim Acta 1978, 82:1-7.
32. Levantesi G., Scarano M., Marfisi R., Borrelli G., Rutjes A.W., Silletta M.G., et al. Meta-analysis of effect of statin treatment on risk of sudden death. Am J Cardiol 2007, 100:1644-1650.
33. Weitz-Schmidt G. Lymphocyte function-associated antigen-1 blockade by statins: molecular basis and biological relevance. Endothelium 2003, 10:43-47.
34. Kinlay S., Egido J. Inflammatory biomarkers in stable atherosclerosis. Am J Cardiol 2006, 98:2P-8P.
35. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., et al. Inflamm-aging, an evolutionary perspective on immunosenescence. Ann NY Acad Sci 2000, 908:244-254.
36. Liu V.W., Huang P.L. Cardiovascular roles of nitric oxide: a review of insights from nitric oxide synthase gene disrupted mice. Cardiovasc Res 2008, 77:19-29.
37. John S., Schmieder R.E. Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia. Curr Hypertens Rep 2003, 5:199-207.
38. Soriano F.G., Virag L., Szabo C. Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation. J Mol Med 2001, 79:437-448.
39. Lefer A.M., Lefer D.J. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res 1996, 32:743-751.
40. Cai H., Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000, 87:840-844.
41. Gimbrone M.A., Topper J.N., Nagel T., Anderson K.R., Garcia-Cardena G. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann NY Acad Sci 2000, 902:230-239. (discussion 239-240).
42. Drexler H., Zeiher A.M., Meinzer K., Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991, 338:1546-1550.
43. Cooke J.P., Singer A.H., Tsao P., Zera P., Rowan R.A., Billingham M.E. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992, 90:1168-1172.
44. Zhang C., Hein T.W., Wang W., Chang C.I., Kuo L. Constitutive expression of arginase in microvascular endothelial cells counteracts nitric oxide-mediated vasodilatory function. FASEB J 2001, 15:1264-1266.
45. 2 impairs endothelium-dependent nitric oxide-mediated dilation of coronary arterioles. Arterioscler Thromb Vasc Biol 2006, 26:2035-2042.
46. Binh PNT, Soda K, Kawakami M, Fukaya H, Abe Y. Effects of arginine and spermine supplementation on lipopolysaccharide-induced bacterial translocation and B-cell apoptosis in Peyer's patches and their association with serum NOx. Submitted for publication.